secwatch / observer
8-K filed June 16, 2023, 7:59 PM ET ticker NVCT CIK 0001875558
other material confidence high sentiment neutral materiality 0.45

Nuvectis Pharma shareholders approve equity plan amendment increasing shares by 1M

Nuvectis Pharma, Inc.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Nuvectis Pharma, Inc. shareholders approved Approval of amendment to Nuvectis Pharma, Inc. Global Equity Incentive Plan (2021) at the 2023-06-16 meeting.

Proposal
equity plan
Outcome
passed
Meeting
2023-06-16
Exact text from the filing
The vote with respect to the approval of an amendment to the Nuvectis Pharma, Inc. Global Equity Incentive Plan (2021) was as follows: Total Votes For Total Votes Against Abstentions Broker Non-Votes 8,984,698 198,029 2,462 3,284,985
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Nuvectis Pharma, Inc. shareholders approved Ratification of Kesselman & Kesselman as independent registered public accounting firm at the 2023-06-16 meeting.

Proposal
auditor ratification
Outcome
passed
Meeting
2023-06-16
Exact text from the filing
The vote with respect to the ratification of Kesselman & Kesselman as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023 was as follows: Total Votes For Total Votes Against Abstentions Broker Non-Votes 12,468,118 616 1,440 -
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Nuvectis Pharma, Inc. shareholders approved Election of Class I director at the 2023-06-16 meeting.

Proposal
director election
Outcome
passed
Meeting
2023-06-16
Exact text from the filing
The votes with respect to the election of the Class I director to hold office until the 2026 annual meeting were as follows: Director Votes For Votes Withheld Broker Non-Votes Ron Bentsur 9,035,321 149,868 3,284,985
View on SEC.gov

Browse all shareholder votes →

Nuvectis Pharma, Inc. filing history →

Source: SEC EDGAR
accession 0001104659-23-072304
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.